Vitae Enim Vitae Scientific, Inc., San Diego, CA

Is Vitae Enim Vitae Scientific, Inc. an FDA-registered 503B outsourcing facility?

Yes. FDA’s registered outsourcing facility list, updated Nov 6, 2026, names Vitae Enim Vitae Scientific, Inc. in San Diego, CA, first registered Jan 2, 2024 and most recently registered Dec 29, 2025. FDA lists it as not yet inspected.

FDA registers outsourcing facilities under section 503B; state boards of pharmacy issue pharmacy licenses separately. FDA’s list does not say which drugs a facility makes.

Location on FDA’s list
San Diego, CA
Initial registration
Jan 2, 2024
Most recent registration
Dec 29, 2025
Last inspection
Not yet inspected
Form 483 issued at last inspection
N/A
Recall after last inspection
N/A
Action on last inspection
N/A
Intends to compound sterile drugs from bulk substances
No

FDA inspections and actions on record

No entry for this facility was matched on FDA’s compounding inspections and actions page (current as of Oct 22, 2026). FDA may list it under a different name, and the page covers actions from 2019 on.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists Vitae Enim Vitae Scientific, Inc., San Diego, CA (FEI number 3014384422), matched to this page by exact name, city and state. It lists 3 inspections: 1 OAI, 2 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Jan 7, 2025Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs): Voluntary Action Indicated (VAI); Monitoring of Marketed Animal Drugs, Feed, and Devices (Veterinary): Voluntary Action Indicated (VAI)30143844221258264
Sep 22, 2021Official Action Indicated (OAI)Drug Quality Assurance (Drugs): Official Action Indicated (OAI); Unapproved and Misbranded Drugs (Drugs): Official Action Indicated (OAI)30143844221153618
Feb 27, 2019Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs): Voluntary Action Indicated (VAI); Unapproved and Misbranded Drugs (Drugs): Voluntary Action Indicated (VAI)30143844221080750

Form 483s FDA has published for this site

No published Form 483 for FEI 3014384422 was found in the dashboard’s list of published 483s on Nov 15, 2026. FDA publishes only some 483s, so this does not mean none was issued.

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

GLP-1 records in this index

No FDA warning letter or recall report naming a GLP-1 drug in this index, as of Nov 15, 2026, is addressed to this facility’s exact legal name (Vitae Enim Vitae Scientific, Inc.). That is not a finding beyond this index’s search.

The Vitae Enim Vitae Scientific, Inc. pharmacy page answers whether it has had a state board action or FDA letter, from the same FDA lists.

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.